Mohamed Issa compensation by year
INCYTE Summary Compensation Table · the one fiscal year held| Component | FY2025 |
|---|---|
| Salary | $690,411 |
| Bonus | $1,000,000 |
| Stock awards | $7,870,118 |
| Option awards | $450,983 |
| Non-equity incentive | $533,610 |
| Pension and deferred compensation | $0 |
| All other | $47,660 |
| Total | $10,592,782 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: INCYTE CORP DEF 14A filed April 28, 2026, accession 0000879169-26-000031, and prior-year filings. Open the filing on EDGAR.
How this page was built: the INCYTE CORP filed document, accession 0000879169-26-000031. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 48,671 | $4,807,235 | — |
| RSU | 27,812 | $2,746,991 | — |
| PSU | 21,923 | $2,165,335 | — |
| RSU | 8,769 | $866,114 | — |
| Option | 19,735 | — | $68.25 |
Per the Outstanding Equity Awards at Fiscal Year-End table in INCYTE CORP's FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Change-in-control & termination
estimated payments INCYTE discloses, by trigger · FY2025| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Change in control and involuntary termination | $2,549,726 | $11,620,995 | $26,997 | $14,251,564 |
| Death | $0 | $854,250 | $0 | $908,096 |
| Disability | $0 | $854,250 | $0 | $908,096 |
| Involuntary termination without cause | $0 | $854,250 | $0 | $908,096 |
Per the Potential Payments Upon Termination or Change in Control table in INCYTE CORP's FY2025 proxy. Estimates as the company printed them; a dash means it printed no figure.
INCYTE’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| William Meury | Chief Executive Officer | $32,085,952 |
| Mohamed Issa · this page | Executive Vice President and Head of U.S. Commercial | $10,592,782 |
| Pablo Cagnoni | President and Global Head of Research and Development | $8,838,961 |
| Herve Hoppenot | Former President and Chief Executive Officer | $6,380,525 |
| Steven Stein | Executive Vice President, Chief Medical Officer and Head of Late-stage Development | $6,304,172 |
| Christiana Stamoulis | Former Executive Vice President and Chief Financial Officer | $4,936,550 |
| Thomas Tray | Vice President, Chief Accounting Officer and Principal Financial Officer | $990,368 |
The full INCYTE compensation record
free company briefThis page is one person within INCYTE's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the INCYTE proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order INCYTE's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are INCYTE's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order INCY
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.